Weber J, Mandala M, Del Vecchio M, Gogas HJ, Arance AM, Cowey CL, et al. Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma. N Engl J Med 2017 Sep 10 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/28891423.
Compare quality appraisals for each clinical question
- Should all patients with a positive sentinel lymph node biopsy have a complete node dissection?
- What is the role of adjuvant systemic therapy in patients with resected stage II and stage III melanoma?
- When is sentinel lymph node biopsy (SLNB) indicated?